Peptide

AHK-Cu

Also known as

AHK copper peptide · Ala-His-Lys copper · AHK-Cu copper tripeptide · L-alanyl-L-histidyl-L-lysine-Cu2+ · copper AHK · copper tripeptide-3 (cosmetic INCI / supplier contexts) · tripeptide-copper complex (AHK context) · Ala-His-Lys-Cu

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Identity	A copper-binding peptide made from alanine, histidine and lysine, discussed mainly for scalp hair. GHK-Cu begins with a different amino acid.
Forms differ	Topical cosmetics, powder added to serum and injected research products are different exposures. A scalp report cannot establish an injection's effects.

Notes

Three amino acids carrying copper. AHK means alanine, histidine and lysine; GHK-Cu starts with glycine instead. Forums call AHK hair-focused, without establishing that it outperforms GHK. Pyo et al. (2007): The Effect of Tripeptide-Copper Complex on Human Hair Growth In Vitro (Official context · Accessed 2026-09-30) · AHK-Cu vs GHK-Cu — topical nonresponse (Personal report · Accessed 2026-09-30)

AHK-Cu is a copper-binding peptide discussed mainly for scalp hair: thicker-looking strands, less shedding and new small hairs. Topical reports range from encouraging to unchanged, often alongside other treatments. Injection stories describe a separate experiment with uncertain benefit and conflicting pain reports.

A scalp serum and an injection are different exposures. Finished cosmetics, powder added to water-based serums and injectable research vials differ. Results from one form cannot establish another's effects. Facial use largely borrows GHK's skin story. Injecting AHK-CU — plans, updates and opposing pain reports (Community discussion · Accessed 2026-09-30)

Source context — Pyo et al. (2007): The Effect of Tripeptide-Copper Complex on Human Hair Growth In Vitro: Third-party full-text mirror. Laboratory human tissue/cells, not treatment of people; no topical or injection PK. Class/GHK background must not become an AHK experimental result.

Source context — AHK-Cu vs GHK-Cu — topical nonresponse: Dose, purity and application frequency unspecified. Other replies' GHK results cannot count as AHK outcomes. No support for reply claiming microneedling is mandatory.

Source context — Injecting AHK-CU — plans, updates and opposing pain reports: OP also writes 2.5g, inconsistent with mg posts; not silently corrected. Self-reported identity and effects unverified. Mixed GHK/AHK threads obscure attribution. More-replies not all expanded; TikTok original not inspected. Relative times not exact dates.

What people notice

Hair changes	Some describe thicker-looking strands, less shedding or new small hairs. Many also use minoxidil, anti-androgens, GHK-Cu or needling, so their reports cannot show AHK-Cu's share of the change.
No clear growth	One topical user saw nothing after two months. Older 2% and 5% users reported no gain or stabilization; thicker-feeling hair sometimes came without visible new growth.

Notes

Baby hairs, thickness or less shedding. People seek gradual hair changes rather than an acute mental or energy effect. Fuller-feeling strands and photographed new growth are different outcomes. Topical GHK/AHK? — AHK-specific nine-week account (Personal report · Accessed 2026-09-30) · AHK-Cu vs GHK-Cu — topical nonresponse (Personal report · Accessed 2026-09-30) · AHK-Cu hair serum (DIY) (Community discussion · Accessed 2026-09-30)

AHK's contribution often stays unclear. Minoxidil, anti-androgens, GHK and needling accompany many stories. One dual-copper user reported possibly less shedding around 45 days while using topical/oral minoxidil, dutasteride and KLOW. Has anyone here used AHK-Cu for hair loss? (Community discussion · Accessed 2026-09-30)

Two months can also mean no change. A raw-AHK hair-tonic user noticed nothing after two months. Around a month, the injection OP still reported minoxidil-related shedding and uncertainty. AHK-Cu vs GHK-Cu — topical nonresponse (Personal report · Accessed 2026-09-30) · Injecting AHK-CU — plans, updates and opposing pain reports (Community discussion · Accessed 2026-09-30)

More concentrated did not reliably mean better. In 2012, a 2% user reported no gain and apparent temple thinning after a month; a 5% user reported no stabilization from March to August. Another saw possible regrowth alongside shedding after three months. Co-treatments complicate every result. Any luck with AHK-CU (Community discussion · Accessed 2026-09-30)

Thicker-looking hair can precede any visible growth. A DIY follow-up describes thicker-feeling hair without clear additional growth. Another AHK-serum user reports healthy-looking hair but no clear new-growth result. AHK-Cu hair serum (DIY) (Community discussion · Accessed 2026-09-30) · Has anyone here used AHK-Cu for hair loss? (Community discussion · Accessed 2026-09-30)

Source context — Topical GHK/AHK? — AHK-specific nine-week account: Unverified amount and product. Same username as the preserved later report: not an independent additional person. Retrieved relative timestamps conflict between versions; no exact publication date inferred.

Source context — AHK-Cu hair serum (DIY): DIY concentrations not assayed. OP later mentions injecting, so longer outcomes do not cleanly describe topical-only use. Vehicle/preservative chemistry and fridge-life suggestions are opinions, not tested stability. No recipes reproduced.

Source context — Has anyone here used AHK-Cu for hair loss?: Anonymous reports, blends and multiple treatments. Facial-hair warning does not clearly identify which copper peptide caused it. Bottle volume unspecified for equal-gram blend. No clinical response rate.

Source context — Any luck with AHK-CU: 2012 unverified preparations and co-treatments; subjective worsening is not proof of peptide-induced loss.

Doses people talk about

Topical chart bands	Saved discussions include 0.05–0.2% and 0.1–1% serums, with 2–5 drops or 0.25–1 mL per application once or twice daily. Percentage alone does not give applied milligrams.
Separate serum reports	One user described 1% AHK-Cu nightly. Another favored 3–5% AHK-Cu plus 3–5% GHK-Cu; those are separate component percentages, not a combined 3–5% total.
Injection account	One poster planned 2 mg five days weekly, then reported 3 mg daily with uncertain benefit. This is a separate exposure from topical use, with no established dose standard.

Notes

Topical percentages vary widely. Preserved discussions include 0.05–0.2% and 0.1–1% scalp serums; the first means 0.5–2 mg/mL if weight/volume. Reported application amounts span 2–5 drops or 0.25–1 mL, once or twice daily. Percentage alone cannot give applied milligrams.

1% nightly and higher mixed-serum claims coexist. One DIY poster reports 1% AHK in an HA/B5 serum, nightly. Another favors 3–5% AHK plus 3–5% GHK: component percentages, not a single 3–5% total. Neither is an assayed optimal range. AHK-Cu hair serum (DIY) (Community discussion · Accessed 2026-09-30)

Injection: 2 mg five days weekly, later 3 mg daily. The OP's TikTok-inspired plan became an abdomen-injection account with uncertain benefit. The same thread contains an inconsistent gram-unit post that cannot safely be normalized. Preserved vendor/social charts also circulate 50–200 mcg, 0.5–1 mg and 1–2 mg subcutaneous amounts, sometimes 3–5 times weekly; these are separate claims. Injecting AHK-CU — plans, updates and opposing pain reports (Community discussion · Accessed 2026-09-30)

Half-life, onset & duration

Felt onset	One topical user reported baby hairs appearing during the last two weeks of a nine-week course. There is no dependable response window.
Felt duration	Single-application duration and persistence after stopping are unknown in these records. Months of repeated application do not establish either.
Half-life	No measured human value is established for topical or injected AHK-Cu. Daily habits, serum shelf life and GHK estimates do not supply it.

Notes

New baby hairs around nine weeks in one account. A topical user reports 2.5 mg daily for nine weeks, with baby hairs appearing in the previous two weeks. Their later preserved account describes 2–3 months of daily use with long-term minoxidil, alfatradiol and recent needling. These are the same person's reports, not two independent successes. Topical GHK/AHK? — AHK-specific nine-week account (Personal report · Accessed 2026-09-30)

Single-application duration is unknown. Months of repeated use do not reveal hours of activity per application. Clean stop-and-follow-up reports are too scarce to establish persistence. Has anyone here used AHK-Cu for hair loss? (Community discussion · Accessed 2026-09-30)

No measured human value in these reports. Neither scalp nor injection accounts measure intact AHK-Cu clearance. Daily application habits, GHK estimates and refrigerated-serum life cannot supply an AHK human half-life. Injecting AHK-CU — plans, updates and opposing pain reports (Community discussion · Accessed 2026-09-30)

Cycles people discuss

Topical observation	Continuous use is often judged with photos over 3–6 months. Irritation pauses and stopping after no benefit appear, without a validated on/off cycle.
Injection calendars	The injection poster borrowed GHK's five-days-on, weekends-off habit, then reported daily use. Neither establishes a preferred AHK-Cu cycle.

Notes

Continuous topical use, often judged over 3–6 months. This photo-observation habit is not a validated on/off cycle. Reports include irritation pauses, stopping after no benefit and later restarts; multi-year follow-up is limited.

Injection breaks are borrowed routines. The OP copied GHK's five-days-on, weekends-off habit, then reported daily use. Replies favoring continuous use establish no preferred cycle. Injecting AHK-CU — plans, updates and opposing pain reports (Community discussion · Accessed 2026-09-30)

Stacks

Dual copper	Reports combine AHK-Cu with GHK-Cu, including roughly 1% AHK with 1–2% GHK. Another lists 1 g of each without bottle volume, so its final percentages are unknown.
Hair routines	Minoxidil, finasteride or dutasteride, needling, caffeine and scalp massage appear alongside AHK-Cu. These combinations do not isolate its effect or establish extra benefit.

Notes

Combining products makes comparison difficult. One serum report combines 1 g AHK and 1 g GHK: a 1:1 peptide-mass blend without bottle volume. Older notes discuss roughly 1% AHK with 1–2% GHK, alongside minoxidil, anti-androgens, caffeine, massage or topical spironolactone. Has anyone here used AHK-Cu for hair loss? (Community discussion · Accessed 2026-09-30)

+ Finasteride / dutasteride / RU-style anti-androgens: Standard AGA stacks with copper serum as adjunct — attribution nearly impossible. [community]

Watch for

Scalp irritation	Stinging, itching, dryness, flaking and blue-green staining are reported. Persistent rash can reflect dermatitis or copper sensitivity.
Stronger is unproven	Higher concentrations inhibited growth in isolated-follicle work. That laboratory result cannot choose a human scalp percentage or injection amount.
Injection and needling	Injection pain reports conflict, and benefit remains uncertain. Needling adds bleeding and infection risks; blue color cannot verify purity or sterility.

Notes

Stinging, itching, dryness and staining. Topical notes include irritation, flaking and blue-green marks on skin, hair or bedding. Color, pleasant cooling and tolerability cannot prove identity or benefit. AHK-Cu hair serum (DIY) (Community discussion · Accessed 2026-09-30)

Copper sensitivity and contact allergy. The original caution cites a 2014 copper-allergy review. This is context about copper exposure generally, not an AHK-Cu trial or reaction rate; persistent itching or a rash can reflect dermatitis rather than ordinary application feel. 2014 copper/contact-dermatitis review cited in the frozen original (PMID 25098945) (Official context · Accessed 2026-09-30)

Laboratory follicles, not a treated scalp. Pyo's 2007 study used isolated human follicles and cells. Low culture concentrations promoted elongation; higher ones inhibited it. These results explain interest but cannot select a scalp percentage, injection amount or human half-life. VEGF and TGF-β background concerns GHK/class literature, rather than measured AHK endpoints. Pyo et al. (2007): The Effect of Tripeptide-Copper Complex on Human Hair Growth In Vitro (Official context · Accessed 2026-09-30)

Injection comfort reports conflict. One poster calls AHK milder than GHK; another calls it worse while claiming thicker hair and smoother skin. Later bruising discussion mixes compounds, so it cannot supply an AHK-specific rate. The OP remains unsure whether injections helped. Injecting AHK-CU — plans, updates and opposing pain reports (Community discussion · Accessed 2026-09-30)

Needling adds its own risks. Legacy routines describe 0.5–1.5 mm, weekly to every ten days. Those reports cannot settle risks from broken/infected skin, bleeding or poor hygiene. Comfortable serum use does not establish injection or needling safety. AHK-Cu hair serum (DIY) (Community discussion · Accessed 2026-09-30)

Powder, blends and labels leave unanswered questions. Blue color cannot prove purity or sterility. Long-term systemic copper exposure and pregnancy, breastfeeding or pediatric research-use safety remain poorly characterized. GLOW/KLOW use GHK-Cu as the copper component; their stories do not validate swapping in AHK.

Source context — 2014 copper/contact-dermatitis review cited in the frozen original (PMID 25098945): Formal copper-class context retained from the frozen record. Current PubMed retrieval returned minimal text and Europe PMC was blocked; no new full-text or abstract verification claimed. No AHK-specific prevalence or causal attribution assigned.

Full notes

What AHK-Cu is

Three amino acids carrying copper. AHK means alanine, histidine and lysine; GHK-Cu starts with glycine instead. Forums call AHK hair-focused, without establishing that it outperforms GHK. Official context Personal report
A scalp serum and an injection are different exposures. Finished cosmetics, powder added to water-based serums and injectable research vials differ. Results from one form cannot establish another's effects. Facial use largely borrows GHK's skin story. Community Community Reddit r/HairlossResearch

What people hope to notice

Baby hairs, thickness or less shedding. People seek gradual hair changes rather than an acute mental or energy effect. Fuller-feeling strands and photographed new growth are different outcomes. Personal report Personal report Reddit r/Hairtransplant
AHK's contribution often stays unclear. Minoxidil, anti-androgens, GHK and needling accompany many stories. One dual-copper user reported possibly less shedding around 45 days while using topical/oral minoxidil, dutasteride and KLOW. Reddit r/Biohacking

Doses people discuss

Descriptions of reported use, not instructions or a personal regimen.

Topical percentages vary widely. Preserved discussions include 0.05–0.2% and 0.1–1% scalp serums; the first means 0.5–2 mg/mL if weight/volume. Reported application amounts span 2–5 drops or 0.25–1 mL, once or twice daily. Percentage alone cannot give applied milligrams. Community
1% nightly and higher mixed-serum claims coexist. One DIY poster reports 1% AHK in an HA/B5 serum, nightly. Another favors 3–5% AHK plus 3–5% GHK: component percentages, not a single 3–5% total. Neither is an assayed optimal range. Reddit r/Hairtransplant
Historical 2.5–5% calculations borrowed other copper-peptide data. A 2012 poster proposed 1 mL of 2.5% twice daily and called it 47.4 mg/day using assumed density. The thread borrowed PC1031 results, then mislabeled them AHK; this is forum extrapolation, not an AHK trial dose. HairLossTalk
Injection: 2 mg five days weekly, later 3 mg daily. The OP's TikTok-inspired plan became an abdomen-injection account with uncertain benefit. The same thread contains an inconsistent gram-unit post that cannot safely be normalized. Preserved vendor/social charts also circulate 50–200 mcg, 0.5–1 mg and 1–2 mg subcutaneous amounts, sometimes 3–5 times weekly; these are separate claims. Reddit r/HairlossResearch Community

Half-life

No measured human value in these reports. Neither scalp nor injection accounts measure intact AHK-Cu clearance. Daily application habits, GHK estimates and refrigerated-serum life cannot supply an AHK human half-life. Reddit r/HairlossResearch Community

When changes are reported

New baby hairs around nine weeks in one account. A topical user reports 2.5 mg daily for nine weeks, with baby hairs appearing in the previous two weeks. Their later preserved account describes 2–3 months of daily use with long-term minoxidil, alfatradiol and recent needling. These are the same person's reports, not two independent successes. Personal report Community
Two months can also mean no change. A raw-AHK hair-tonic user noticed nothing after two months. Around a month, the injection OP still reported minoxidil-related shedding and uncertainty. Personal report Reddit r/HairlossResearch

How long an effect lasts

Single-application duration is unknown. Months of repeated use do not reveal hours of activity per application. Clean stop-and-follow-up reports are too scarce to establish persistence. Community Reddit r/Biohacking
Product freshness is a separate clock. DIY debates about carriers, preservation and refrigeration do not measure bodily duration or validate a modified serum's shelf life. Reddit r/Hairtransplant

Courses and breaks people discuss

Continuous topical use, often judged over 3–6 months. This photo-observation habit is not a validated on/off cycle. Reports include irritation pauses, stopping after no benefit and later restarts; multi-year follow-up is limited. Community
Injection breaks are borrowed routines. The OP copied GHK's five-days-on, weekends-off habit, then reported daily use. Replies favoring continuous use establish no preferred cycle. Reddit r/HairlossResearch

What can complicate the experiment

Stinging, itching, dryness and staining. Topical notes include irritation, flaking and blue-green marks on skin, hair or bedding. Color, pleasant cooling and tolerability cannot prove identity or benefit. Community Reddit r/Hairtransplant
Copper sensitivity and contact allergy. The original caution cites a 2014 copper-allergy review. This is context about copper exposure generally, not an AHK-Cu trial or reaction rate; persistent itching or a rash can reflect dermatitis rather than ordinary application feel. Official context
Needling adds its own risks. Legacy routines describe 0.5–1.5 mm, weekly to every ten days. Those reports cannot settle risks from broken/infected skin, bleeding or poor hygiene. Comfortable serum use does not establish injection or needling safety. Community Reddit r/Hairtransplant
Powder, blends and labels leave unanswered questions. Blue color cannot prove purity or sterility. Long-term systemic copper exposure and pregnancy, breastfeeding or pediatric research-use safety remain poorly characterized. GLOW/KLOW use GHK-Cu as the copper component; their stories do not validate swapping in AHK. Community

What the experiences add

More concentrated did not reliably mean better. In 2012, a 2% user reported no gain and apparent temple thinning after a month; a 5% user reported no stabilization from March to August. Another saw possible regrowth alongside shedding after three months. Co-treatments complicate every result. HairLossTalk
Thicker-looking hair can precede any visible growth. A DIY follow-up describes thicker-feeling hair without clear additional growth. Another AHK-serum user reports healthy-looking hair but no clear new-growth result. Reddit r/Hairtransplant Reddit r/Biohacking
Injection comfort reports conflict. One poster calls AHK milder than GHK; another calls it worse while claiming thicker hair and smoother skin. Later bruising discussion mixes compounds, so it cannot supply an AHK-specific rate. The OP remains unsure whether injections helped. Reddit r/HairlossResearch
Combining products makes comparison difficult. One serum report combines 1 g AHK and 1 g GHK: a 1:1 peptide-mass blend without bottle volume. Older notes discuss roughly 1% AHK with 1–2% GHK, alongside minoxidil, anti-androgens, caffeine, massage or topical spironolactone. Reddit r/Biohacking Community
Vehicle feel and untested layering habits. Reports describe greasy hair-serum mixing, a thick HA base and pleasant cooling. Preserved layering habits separate minoxidil and copper by 15–20 minutes or morning/evening; neither is measured absorption or a proven chemistry safeguard. Reddit r/Biohacking Reddit r/Hairtransplant Community
Unwanted facial hair is a reported concern. A commenter links an injection warning for women to facial hair, without isolating AHK from GHK. This is a reported concern, not an AHK-specific incidence. Reddit r/Biohacking

What the supporting evidence answers

Laboratory follicles, not a treated scalp. Pyo's 2007 study used isolated human follicles and cells. Low culture concentrations promoted elongation; higher ones inhibited it. These results explain interest but cannot select a scalp percentage, injection amount or human half-life. VEGF and TGF-β background concerns GHK/class literature, rather than measured AHK endpoints. Official context
Commercial numbers have a different origin. The preserved record repeats supplier use-levels of 0.3–1%, guides around 0.5–1% or 0.3–2%, and outliers of 2–5% or maximum 10%. These are formulation/marketing claims, not human dose-finding or proof that stronger products work better. Community
Precise online timing can be unsupported. A sales-linked guide asserts 45–90 minutes in plasma and 6–12 hours of activity without a traceable AHK measurement in its retrieved article. Those figures remain vendor claims, excluded from the practical half-life and duration answers. Community guide